Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.35 USD | -0.74% | +1.50% | +15.38% |
May. 13 | HC Wainwright Adjusts Price Target on Clearside Biomedical to $5 From $6, Keeps Buy Rating | MT |
May. 09 | Transcript : Clearside Biomedical, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.38% | 101M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.43% | 22.1B | |
-8.40% | 18.34B | |
-41.70% | 16.59B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- CLSD Stock
- News Clearside Biomedical, Inc.
- JonesTrading Intiates Coverage on Clearside Biomedical With Buy Rating, $6 Price Target